Abstract:
OBJECTIVES:The safety and efficacy of a single-rod implantable contraceptive containing etonogestrel (Implanontrade mark) were investigated in a multicenter clinical trial. STUDY DESIGN:Sexually active American women (N=330) with apparently normal menstrual cycles used the implant for up to 2 years. All subjects recorded bleeding and/or spotting daily in a diary. Safety was assessed through adverse experiences (AEs), laboratory tests and physical and gynecologic examinations. RESULTS:Total exposure was 474 woman-years (6186 cycles), and 68% of subjects had at least 1 year of exposure. No pregnancies occurred. The most common bleeding pattern observed throughout the study was infrequent bleeding, defined as less than three episodes of bleeding in a reference period (excluding amenorrhea). The least common pattern was frequent bleeding, defined as more than five episodes of bleeding in a reference period. Infrequent, prolonged and frequent bleeding patterns were most common early in the study and declined thereafter. During the 3-month Reference Periods 2-8 (Months 4-24), the incidence of amenorrhea ranged from 14% to 20%. Forty-three subjects (13%) withdrew from the study because of bleeding pattern changes and 76 subjects (23%) discontinued because of other AEs. Other common AEs leading to discontinuation, besides bleeding irregularities, were emotional lability (6.1%), weight increase (3.3%), depression (2.4%) and acne (1.5%). Use of Implanon (etonogestrel subdermal implant, referred to herein as ENG implant) for up to 2 years had no clinically significant effects on laboratory parameters, physical and pelvic examinations, vital signs or body mass index. The average length of time required for ENG implant insertion and that for removal were 0.5 and 3.5 min, respectively, and all the procedures were uncomplicated. The return to normal menstrual cycles and fertility was rapid after removal. CONCLUSIONS:Implanon is a safe, highly effective and rapidly reversible new method of contraception.
journal_name
Contraceptionjournal_title
Contraceptionauthors
Funk S,Miller MM,Mishell DR Jr,Archer DF,Poindexter A,Schmidt J,Zampaglione E,Implanon US Study Group.doi
10.1016/j.contraception.2004.11.007subject
Has Abstractpub_date
2005-05-01 00:00:00pages
319-26issue
5eissn
0010-7824issn
1879-0518pii
S0010-7824(04)00310-5journal_volume
71pub_type
临床试验,杂志文章,多中心研究相关文献
CONTRACEPTION文献大全abstract:OBJECTIVES:Federally Qualified Health Centers (FQHCs) are a major and growing source of primary care for low-income women of reproductive age; however, only limited knowledge exists on the scope of family planning care they provide and the mechanisms for delivery of these essential reproductive health services, includi...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2013.09.015
更新日期:2014-02-01 00:00:00
abstract:PURPOSE:Quantitative evaluation of properties of bromhexine (B) for expression of uterine proteins in ovariectomized (OVX) and pregnant rats. MATERIALS AND METHODS:Expression of proteins through SDS-PAGE, along with incorporation of glycosidic moieties, was conducted in pregnant and OVX rats under B influence. These f...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2005.11.006
更新日期:2006-06-01 00:00:00
abstract::An injectable method of obtaining vas deferens occlusion is presented. The agent used is styrene maleic anhydride (SMA) with dimethyl sulphoxide as the solvent. The special feature of the approach is that after a period of time, spermatozoa passage is spontaneously reestablished. By varying the dose of SMA administere...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(90)90073-5
更新日期:1990-03-01 00:00:00
abstract:BACKGROUND:There is a lack of information concerning the decision factors and sources of information influencing women who purposefully deviate from the prescribed use of their combined hormone contraceptives to exert elective control of their scheduled bleeding. STUDY DESIGN:A self-administered email survey of schedu...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2012.12.012
更新日期:2013-09-01 00:00:00
abstract:CONTEXT:There is concern that a new transdermal contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin increases the risk for venous thromboembolism (VTE) compared to previously marketed oral contraceptives (OCs). OBJECTIVE:Quantitative information was obtained on the risk of nonfatal V...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2006.01.001
更新日期:2006-03-01 00:00:00
abstract::Levels of contraceptive steroids in breast milk and plasma of lactating women were investigated. 7 lactating women received 150 mg medroxyprogesterone acetate (MPA) 1 week after delivery. 5 women (lactating) took 350 mcg norethisterone (NET) and 2 took 150 mcg d-norgestrel (d-ng) + 30 mcg ethinyl estradiol. Milk an...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(77)90061-0
更新日期:1977-12-01 00:00:00
abstract::After exposure of young male rats to gossypol acetic acid for various times, a reduction in the content of cellular and microtubular beta-tubulin was found in spermatocytes and spermatids. The content of tubulin was measured by enzyme-linked immunosorbent assay (ELISA). The results were expressed as micrograms tubulin...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(96)00240-5
更新日期:1997-01-01 00:00:00
abstract::For the first time in the 21st century, we have an emerging body of research regarding contraceptive use among adult women with disabilities in the United States. We highlight key findings from population-based analyses that found higher odds of female sterilization and lower odds of long-acting reversible contracepti...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2019.01.006
更新日期:2019-05-01 00:00:00
abstract::Roussel Uclaf in partnership with the INSERM unit of Prof. E.E. Baulieu first discovered mifepristone (RU486) as part of a large research program on steroidal compounds with antihormone properties. Exhibiting a strong affinity to the progesterone and the glucocorticoid receptors, mifepristone exerted competitive antag...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(03)00171-9
更新日期:2003-12-01 00:00:00
abstract:OBJECTIVE:To evaluate the initial safety and effectiveness of the intrauterine ball (IUB), a copper intrauterine device that, upon insertion in the uterus, takes a three-dimensional spherical form. STUDY DESIGN:Fifteen women were followed for 1 year, with follow-up visits at 1, 3, 6, 9 and 12 months. RESULTS:The phys...
journal_title:Contraception
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.contraception.2013.10.017
更新日期:2014-02-01 00:00:00
abstract::The efficacy of administering an antibiotic prior to IUD insertion to reduce the risk of introducing an upper genital tract infection during the procedure has not yet been established. Two double-blind randomized studies conducted in Africa comparing a 200 mg prophylactic dose of doxycycline with a placebo did not con...
journal_title:Contraception
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/0010-7824(94)90019-1
更新日期:1994-10-01 00:00:00
abstract:OBJECTIVE:To determine the acceptability of taking mifepristone at home for early medical abortion in the United States. STUDY DESIGN:This prospective, non-randomized, open-label study at six Planned Parenthood centers gave women with pregnancies up to 63 days' gestation seeking medical abortion the choice of taking m...
journal_title:Contraception
pub_type: 临床试验,杂志文章,多中心研究
doi:10.1016/j.contraception.2015.06.026
更新日期:2015-09-01 00:00:00
abstract::Researchers, health care providers, women's health advocates, donors, and representatives of ministries of health convened in Bellagio, Italy, in July 1998, to assess the potential of medical methods of early pregnancy termination to improve the reproductive health of women in developing countries. Consensus was reac...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(98)00109-7
更新日期:1998-11-01 00:00:00
abstract::The ability of the condom wall to maintain its integrity throughout sexual intercourse is critical to its role in halting the spread of major sexually transmissible pathogens including the human immunodeficiency virus. There are three principal in vitro performance tests applied to condoms: a test for freedom from hol...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(91)90045-h
更新日期:1991-02-01 00:00:00
abstract::The exact role of apoptosis that occurs in human placenta during the early stage of pregnancy remains unknown because of the difficulty in obtaining the intact implantation site. In this study, we used rhesus monkey as an animal model to examine apoptosis occurring in the implantation site at various stages of early p...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(01)00241-4
更新日期:2001-09-01 00:00:00
abstract::Experiments were conducted to determine whether oral administration of a water extract of P. dodecandra had significant effects on reproduction in mice. The work is based on earlier reports in this journal that butanol extracts of the berries of this plant had spermatocidal properties in vitro and blastocidal activity...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(87)80006-9
更新日期:1987-02-01 00:00:00
abstract:BACKGROUND:User profile, continuation rate, reasons for discontinuation, problems during insertion and removal, and effectiveness of an etonogestrel subdermal contraceptive implant (ESCI) were assessed. STUDY DESIGN:A follow-up of 372 women 3 years after insertion of an ESCI performed by family physicians in Granada, ...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2009.04.003
更新日期:2009-11-01 00:00:00
abstract::In a case-control study of 1647 breast cancer cases and 1501 population controls under 45 years of age, potential modifying effects of other risk factors on the relationship of oral contraceptives to breast cancer were examined. Among the total series of study subjects, the relationship of extended pill usage was grea...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/s0010-7824(97)00012-7
更新日期:1997-04-01 00:00:00
abstract::A non-randomized comparative clinical trial of the progestin-only oral contraceptive (POC), Ovrette (75 mcg norgestrel) (Wyeth), versus non-hormonal methods was conducted at two clinics in Buenos Aires, Argentina. The trial was designed to assess the breast-feeding patterns of women choosing progestin-only oral contra...
journal_title:Contraception
pub_type: 临床试验,杂志文章
doi:10.1016/0010-7824(91)90104-n
更新日期:1991-07-01 00:00:00
abstract:BACKGROUND:Maternal trisomy 21 ovarian mosaicism might provide the major causative factor for fetal Down syndrome. The small proportion of trisomy 21 oocytes thought to be retarded in their maturation in comparison to normal disomic ones, and the maternal age effect can be based on an accumulation of trisomy 21 oocytes...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2012.08.040
更新日期:2013-04-01 00:00:00
abstract::The objectives of the study were to assess the ability of the Femcap, a new vaginal contraceptive device made of silicone and designed to fit snugly around the cervix to prevent the penetration of sperm into midcycle cervical mucus when used with and without spermicide; and to compare it with the standard contraceptiv...
journal_title:Contraception
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/s0010-7824(97)00098-x
更新日期:1997-08-01 00:00:00
abstract:OBJECTIVES:There have been conflicting reports of altered vaginal microbiota and infection susceptibility associated with contraception use. The objectives of this study were to determine if intrauterine contraception altered the vaginal microbiota and to compare the effects of a copper intrauterine device (Cu-IUD) and...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2017.05.017
更新日期:2017-09-01 00:00:00
abstract::A randomised cross-over trial was performed to compare the pharmacodynamic actions of three low-dose oral contraceptives (OCs): Marvelon (150 micrograms desogestrel (DSG)+ 30 micrograms ethinyloestradiol (EE)), Mercilon (150 micrograms DSG + 20 micrograms EE) and Microgynon (150 micrograms levonorgestrel (LNG) + 30 mi...
journal_title:Contraception
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/0010-7824(92)90103-z
更新日期:1992-06-01 00:00:00
abstract:BACKGROUND:The pharmacokinetics of the monophasic oral contraceptive nomegestrol acetate (NOMAC) plus 17β-estradiol (E(2)) were investigated after a single dose and multiple dosing. STUDY DESIGN:NOMAC/E2 (2.5 mg/1.5 mg) was administered daily to healthy women (18-50 years, n=23) for 24 days; blood samples for pharmaco...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/j.contraception.2012.07.001
更新日期:2013-02-01 00:00:00
abstract::Socio-demographic characteristics, general lifestyle habits, reproductive and medical histories were compared of 328 women who had ever used oral contraceptives and 2306 never users from a case-control surveillance conducted in Northern Italy. Oral contraceptive use was positively and strongly related with the level o...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(86)90067-3
更新日期:1986-08-01 00:00:00
abstract::This study examines the efficacy and side effects of 15-methyl-prostaglandins F2alpha (PGF2a) free acid administered intramuscularly for midtrimester abortion. 50 healthy women aged 14 to 37 years and between 12 to 18 weeks gestation were randomly selected from the abortion clinic at the Los Angeles County/USC Medica...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(75)90107-9
更新日期:1975-05-01 00:00:00
abstract::RU 486 and three of its metabolites (RU 42633-monodemethyl, RU 42848-didemethyl, and RU 42698-hydroxymetabolite) were determined by HPLC in plasma from nine non-pregnant and 36 pregnant women. Each non-pregnant subject took an oral dose of RU 486 (25, 100, 400 and 600 mg consecutively) once per menstrual cycle. Six of...
journal_title:Contraception
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/0010-7824(93)90004-q
更新日期:1993-08-01 00:00:00
abstract:BACKGROUND:Globally, 14.3% of women of reproductive age use intrauterine contraception (IUC), but the distribution of IUC users is strikingly nonuniform. In some countries, the percentage of women using IUC is <2%, whereas in other countries, it is >40%. Reasons for this large variation are not well documented. The aim...
journal_title:Contraception
pub_type: 杂志文章,评审
doi:10.1016/j.contraception.2013.11.011
更新日期:2014-03-01 00:00:00
abstract:BACKGROUND:This study evaluated the ethinyl estradiol (EE) and levonorgestrel (LNG) pharmacokinetic profiles of AG200-15, a transdermal contraceptive delivery system, compared with a combination oral contraceptive (COC) containing EE 35 mcg and norgestimate 250 mcg. STUDY DESIGN:A Phase 1, open-label, single-center st...
journal_title:Contraception
pub_type: 杂志文章,随机对照试验
doi:10.1016/j.contraception.2011.10.006
更新日期:2012-06-01 00:00:00
abstract::Patterns of bleeding and plasma concentrations of levonorgestrel, progesterone, estradiol, LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. The IUD was designed to release 12 microgram/day. All but two of the volunteers ovulated during treatment. The ovulatory ...
journal_title:Contraception
pub_type: 杂志文章
doi:10.1016/0010-7824(80)90127-4
更新日期:1980-02-01 00:00:00